CJC-1295 W/O DAC 5mg+IPAMORELIN 5mg

CJC-1295 – High-Purity GHRH Research Peptide with Ipamorelin

CJC-1295 (without DAC) combined with Ipamorelin is a high-purity peptide research formulation supplied in lyophilized powder form for controlled laboratory use. This dual-peptide blend pairs CJC-1295 (no DAC), a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin (IPA), a selective growth hormone secretagogue, making it a valuable tool for advanced endocrine and metabolic research.

In experimental research models, CJC-1295 without DAC is widely studied for its role in growth hormone pulsatility, pituitary signaling, and downstream IGF-1–related pathways. When combined with Ipamorelin, this formulation enables researchers to investigate synergistic mechanisms involved in GH release dynamics, metabolic regulation, and body composition signaling under controlled in vitro conditions

CJC-1295 Product Specifications

• Product Name: CJC-1295 (Without DAC) + Ipamorelin

• Form: Lyophilized peptide powder

• Quantity per Vial:

  • 5 mg CJC-1295 (w/o DAC)

  • 5 mg Ipamorelin (IPA)

• Purity: High-purity, research-grade compound

Storage & Handling

• Store unopened vials in a cool, dry environment

• After reconstitution, refrigerate at 2 °C – 8 °C for optimal stability

• Use within the recommended laboratory time frame

⚠️ For Research Use Only

CJC 1295 w/o DAC + IPA from Evolvelabs is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic applications. No claims are made regarding safety or efficacy in any clinical setting.

Terms of Sale

By ordering from Evolvelabs, you confirm that you are a qualified researcher or institution equipped to handle peptides safely. You accept full responsibility for all handling, storage, and experimental use and understand that Evolvelabs assumes no liability for misuse or misinterpretation of this product.